SmallCellSMASHERS

As 2024 comes to a close, we would like to celebrate the advancements made in small cell lung cancer (#SCLC) that provide hope. This tremendous progress by clinical trials reflects the innumerable sacrifices made by such dedicated patients & their wonderful families. Thank you!

Immunotherapy is reshaping care in #SCLC. Join Jonathan W. Goldman, MD, and Misty Dawn Shields, MD, PhD, as they review the evidence and explore therapeutic strategies in extensive- and limited-stage disease. peervoice.com/KBA?PromoCode=… #MedEd @drshieldsmd @SclcSMASHERS @LUNGevity

Never underestimate the power of one. One patient can change everything. Discovery lies in the outliers. Ask why. Follow the science. 🧪🧬🔬 #research #medtwitter #sclc #lcsm #biomarkers #precisionmedicine @SclcSMASHERS @TheShieldsLab @IUCancerCenter @IUMedSchool @MoffittNews @ktgminton @hilalozakinci @OTtheScientist @PareshKumaaar @MyaPrecisionG @MCT_AACR @AACR aacrjournals.org/mct/article-ab…

Is there a role for stigma in lung cancer? What about in small cell lung cancer? No!🚫👎🙅‍♀️ 1) no one deserves lung cancer. 2) lung cancer can impact anyone with lungs, that’s everyone! 3) stigma hurts others with tangible negative impacts - delays in screening, follow ups, treatments and impacts how patients feel. Stigma, out the door. 🚪 You’re not welcome here. ✌️ @lungoncdoc @LUNGevity @SclcSMASHERS @IUCancerCenter @ASCO @TheShieldsLab

#NYLCF26 Excellent session on SCLC new therapies including ADCs/ Bispecifics/TCE and ▶️understanding tumor plasticity- multiple dynamic biomarkers ▶️developing the next generation of trials that take into account patient population, Performance status Co-chairs @StephenVLiu @JhanelleGray #lcsm @SclcSMASHERS @LauraAlderMD @JSabari @triparnasen

A true honor to lead the End Lung Cancer Now team for @IUCancerCenter at the @LungAssociation Fight for Air Climb today up 48 flights of stairs to raise awareness for lung health advocacy and research! So amazing to see our Tom & Julie Wood Lung Cancer Center of Excellence mobile screening unit parked out front of @salesforce tower! Forever grateful to be part of a team of the most amazing champions for lung cancer screening and lung cancer awareness! #screeningsaveslives #getscreened #lcsm #sclc @OTtheScientist @IUCancerCenter @nicolecons @TheShieldsLab @SclcSMASHERS

Thank you @chadinabhan for highlighting the important need of supporting research & awareness to help our patients and their loved ones impacted by small cell. Such a lovely conversation on #healthcareunfiltered with you, my friend! Looking forward to the full interview posting on Tuesday. @SclcSMASHERS @LUNGevity

Α terrific experience to visit #BuenosAires for the launch event of #tarlatamab . So glad for the expanding options for our patients with #SCLC and grateful to share the stage with prominent colleagues from 🇦🇷 Claudio Martin and Lorena Lupinacci Gracias por vuestra hospitalidad amable!! #some #LCSM @Amgen @AmgenOncology @SclcSMASHERS

What is the biology of small cell lung cancer? What are the neuroendocrine subtypes? Can we use therapies to target the NE subtypes? @lungevity #SCLC #meded #lcsm @SclcSMASHERS @SCLCYIForum @SWOG @Annechiangmd

No real progress was made in small cell lung cancer for almost four decades. Recent studies with new agents brought hope. Deciding what therapy for which patients still remains a challenge. Treatment options for #SCLC after progression are limited. In @TheShieldsLab at @IUCancerCenter, we exclusively focus on identifying novel biomarkers, targets, and combinations for #SCLC. Give us a follow if you want to hear more about SCLC research and updates! @LUNGevity @SclcSMASHERS @OTtheScientist @PareshKumaaar

Just published: These findings provide insights into the molecular heterogeneity of small-cell lung cancer and highlight potential biomarkers for targeted therapies. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @teekayowo @GlopesMd @OncoAlert @SclcSMASHERS #SCLC #LCSM

@drshieldsmd @ASCO @IUCancerCenter @centergrove_mag @TheShieldsLab @SclcSMASHERS @SCLCYIForum Beautiful!! 👏🏻👏🏻👏🏻

Beyond proud 🥹 of my trainee Anthony Cuadros on his recent commentary, “One More Lap.” This article was written from the heart with our personal experiences and his unique viewpoints as a young investigator in #SCLC, now published in @ASCO Connections. We detail the lessons learned from competitive swimming, never losing hope, the novel advances bring to small cell lung cancer, and what it means to fight for “One more lap.” ☺️ Anthony is a top swimmer 🏊 in the state of Indiana, a research assistant👨‍🔬 in @TheShieldsLab, and a senior👨‍🎓at @CenterGroveHS. Excited to see what the future will hold for him! ⭐️ @IUCancerCenter @IU_Health @ConquerCancerFd @centergrove_mag @CGSwimming @SclcSMASHERS @SCLCYIForum

Looking forward to our NEXT @SclcSMASHERS Fireside Chat this Friday 2/6 at 12p EST on YouTube! My good friend (co-residents at @VUMChealth) and world renown thoracic oncology expert Dr. Eric Singhi (@lungoncdoc) from @MDAndersonNews will be our guest! We will discuss the importance of #community & #support for patients and their loved ones impacted by #SCLC! Be sure to tune in! 🎧 @LUNGevity @LungCancerRx @YoungLungCancer @LungAssociation @lcrf_org @LiveLung1 @GO2forLungCancr @LungCAN

Join us for a YouTube Live on 2/6, with @lungoncdoc (@MDAndersonNews) as we discuss the role of community and support in people with small cell lung cancer. Tune in: youtube.com/lungevityfound… @sclcsmashers @drshieldsmd @TheShieldsLab #sclc #lungcancer

🫁 New paper in ESMO Open from the #NYLCFSummit2025! sciencedirect.com/science/articl… @fred_hirsch @peters_solange @JairBar4 @RajaFlores @NarjustFlorezMD @FordePatrick @thelouisgros @BalazsHalmosMD @dplanchard @ReckampK @triparnasen @drshieldsmd @SclcSMASHERS

Thank you to moderators Ann Steagall RN @nursesteagall and Dr. Upal Roy @LUNGevity for a lovely discussion. In our latest @SclcSMASHERS Fireside Chat, we highlighted @TheShieldsLab research, including recent biomarker discoveries for response to lurbinectedin, active liquid biopsy studies, and upcoming clinical trials. I am so honored to partner with you both and the incredible @LUNGevity team. Thank you for your passion, kindness, care, education, and support of our amazing patients and loved ones impacted by #SCLC. @IUCancerCenter @OTtheScientist @PareshKumaaar @triparnasen @ConquerCancerFd @ASCO

As we wrap up 2025, there is an overwhelming gratefulness in my heart ❤️ for the unprecedented advancements 🧬 in treatments 💊 & research 🔬 for #SCLC! Options that improved the care and lives of patients and their loved ones impacted by #SCLC! Thank you to ALL of the patients, families, advocates, researchers, investigators, trainees, nurses, pharmacists, healthcare personnel, philanthropy funding, pharmaceutical companies, and so many more… who sacrificed, invested, dreamed, and believed change COULD exist to ALTER the trajectory of this challenging disease. These breakthroughs MATTER. Each one helped gain one more moment, memory, hug, smile, day, month, year, or life back. Thank you, 2025, for this much needed change. 🙏 I am forever grateful. Hopeful for what 2026 may bring. 🎉 #hope #researchcurescancer #onedayatatime #ittakesateam #neverstop @IUCancerCenter @SclcSMASHERS @LUNGevity @TheShieldsLab @ASCO @ConquerCancerFd @OncBrothers @OncLive @gotoPER @oncodaily @Larvol @cancerGRACE @lungoncdoc @jillfeldman4 @MontessaLee @JackWestMD @StephenVLiu @NarjustFlorezMD @triparnasen @LaurenByersMD @chadinabhan @HemOncFellows @SCLCYIForum

NOW ON YOUTUBE! Join the @SCLCSmashers conversation on January 9 w/ @drshieldsmd (@theshieldslab) moderated by @lungevity's Dr. Upal Basu Roy and Ann Fish-Steagall. Tune in by visiting @LUNGevityFoundation" target="_blank" rel="nofollow noopener">youtube.com/@LUNGevityFoun… #lcsm #smallcell #lungcancer

Join us on 11/25 for a Facebook Live w/ Dr. Trudy Oliver (@DukeMedSchool) to discuss the origins of #smallcell #lungcancer and its impact on plasticity. Moderated by @drshieldsmd (@IUHealth @SCLCSMASHERS) Ann Fish-Steagall (@lungevity). Tune in by visiting facebook.com/lungevity

Our 2nd #keynote speaker, Dr. Greg Kalemkerian from University of Michigan delivers an overview of the current and historic landscape of the treatment of #SCLC @SclcSMASHERS #LCSM #Oncology